Research Assistant

Nuffield Department of Clinical Medicine, Jenner Institute, Old Road Campus Research Building, Roosevelt Drive, Headington, Oxford

Applications to be received by 12pm on Thursday 27th of February 2020

Grade 6: £29,176 - £34,804 p.a.

A role has arisen for a Research Assistant to participate in the Emerging Pathogens vaccine program under the direction of Professor Teresa Lambe. The successful applicant will work to delineate the immune response against Outbreak Pathogens vaccines to aid effective vaccine design. Perform various tasks including ELISPOT, ELISA, flow cytometry and other functional assays as well as perform research in cellular biology including immunofluorescence and sterile cell culture methodologies.

The role requires the applicant to have a first class degree or equivalent in a relevant biological subject as well as some experience in immunology testing and preferably vaccine development. The successful applicant will have the ability to carry out experimental work carefully and safely demonstrating good laboratory practice. The ability to research complex issues and interpret, analyse, and present scientific data is also essential, as well as being technically competent and capable of working independently in the laboratory.

Recently, the Jenner Institute in partnership with Janssen Vaccines, has secured funding from the Coalition of Epidemic Preparedness (CEPI: to continue development of vaccines against three emerging pathogens: Middle Eastern respiratory Syndrome (MERS) coronavirus, Nipah virus and Lassa virus.

Vaccines are one of the world’s most important public health achievements, yet their life-saving potential has not been realised for many emerging epidemic threats. Emerging pathogen outbreaks disproportionately affect low-income countries, where the risks and needs are often greatest, putting immense pressure on already fragile health systems and economies.

The Jenner institute has produced vaccines against malaria, HIV, tuberculosis and influenza, all of which are in clinical development. In recent years there has been a strong interest in the development of vaccines against emerging pathogens such as the MERS and Nipah and Lassa viruses.

Applicants who fulfil the majority of the criteria are encouraged to apply. Applications for this vacancy are to be made online and you will be required to upload a supporting statement and CV as part of your online application.

This post is offered full-time on a 1 year fixed-term contract (from date of advertisement) funded by Coalition for Epidemic Preparedness Innovations (CEPI).

Please quote 145150 on all correspondence.

Only applications received before 12.00 noon on 27 February 2020 will be considered.

Contact: Phillippa Wall (01865 617971)